Marker Therapeutics, Inc. (MRKR)
About Marker Therapeutics, Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2021
- $0
- Net income
- -$12.2M
- Total assets
- $19.1M
- Market cap
- $20.3M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $20.3M
- Shares outstanding
- 21.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 7, 1998
Marker Therapeutics, Inc. (MRKR) Stock Price
- Reported a net loss of $12.2M in FY2021.
- Trading 56% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Marker Therapeutics, Inc..
Write a review
News about Marker Therapeutics, Inc.
News & sentiment via Polygon.io
Marker Therapeutics, Inc.: frequently asked questions
Is Marker Therapeutics, Inc. an American company?
Marker Therapeutics, Inc. is a US-based company headquartered in Houston, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Marker Therapeutics, Inc. headquartered?
Marker Therapeutics, Inc. is headquartered in Houston, Texas, United States.
Is Marker Therapeutics, Inc. publicly traded?
Yes — Marker Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol MRKR on the NASDAQ.
What does Marker Therapeutics, Inc. do?
Marker Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
